PRISMAP final event
On 18–19 November 2025, PRISMAP held its Final Public Event in Warsaw at the Heavy Ion Laboratory (University of Warsaw), with the option to participate online. Hosted by PRISMAP partner the National Centre for Nuclear Research – Radioisotope Centre POLATOM (NCBJ), the two-day meeting brought together the European radiopharmaceutical community to review key achievements of PRISMAP and to discuss lessons learned, conclusions, and the way forward for access to novel medical radionuclides.
The programme opened with “PRISMAP in a nutshell” and a welcome from the Heavy Ion Laboratory, followed by a session dedicated to PRISMAP final results. Speakers shared updates on strategic engagement with emerging infrastructures, advances in target development, ion sources and enrichment techniques, and practical experience gained from four years of transnational transport of novel radionuclides. A dedicated block also highlighted medically relevant radiolanthanides and the PRISMAP service portfolio for radionuclide production and biomedical applications, complemented by an active poster session that encouraged networking and scientific exchange.
Day 2 focused on enabling conditions for clinical and industrial translation. A session on regulatory requirements addressed radiopharmacy experience, challenges in standardisation and harmonisation, and translational data generation, followed by a European perspective keynote on research infrastructures and the need to provide access to novel radionuclides and their biomedical applications. An Industry Collaboration session showcased viewpoints from stakeholders in the radiopharmaceutical community, and the event concluded with selected highlights from PRISMAP-enabled user projects and their impact on theranostics and oncology.
